These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34901195)

  • 1. A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study.
    Akizawa T; Nangaku M; Yamaguchi T; Koretomo R; Maeda K; Miyazawa Y; Hirakata H
    Kidney Dis (Basel); 2021 Nov; 7(6):494-502. PubMed ID: 34901195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 3 Study of Enarodustat in Anemic Patients with CKD not Requiring Dialysis: The SYMPHONY ND Study.
    Akizawa T; Nangaku M; Yamaguchi T; Koretomo R; Maeda K; Miyazawa Y; Hirakata H
    Kidney Int Rep; 2021 Jul; 6(7):1840-1849. PubMed ID: 34307978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
    Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Maeda K; Miyazawa Y; Hirakata H
    Nephron; 2019; 143(2):77-85. PubMed ID: 31117088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Matsui A; Hirakata H
    Am J Nephrol; 2019; 49(2):165-174. PubMed ID: 30699415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two long-term phase 3 studies of enarodustat (JTZ-951) in Japanese anemic patients with chronic kidney disease not on dialysis or on maintenance hemodialysis: SYMPHONY ND-Long and HD-Long studies.
    Akizawa T; Nangaku M; Yamaguchi T; Koretomo R; Maeda K; Yamada O; Hirakata H
    Ther Apher Dial; 2022 Apr; 26(2):345-356. PubMed ID: 34390314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molidustat for Renal Anemia in Nondialysis Patients Previously Treated with Erythropoiesis-Stimulating Agents: A Randomized, Open-Label, Phase 3 Study.
    Yamamoto H; Nobori K; Matsuda Y; Hayashi Y; Hayasaki T; Akizawa T
    Am J Nephrol; 2021; 52(10-11):884-893. PubMed ID: 34569482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
    Provenzano R; Besarab A; Wright S; Dua S; Zeig S; Nguyen P; Poole L; Saikali KG; Saha G; Hemmerich S; Szczech L; Yu KH; Neff TB
    Am J Kidney Dis; 2016 Jun; 67(6):912-24. PubMed ID: 26846333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial.
    Yamamoto H; Nobori K; Matsuda Y; Hayashi Y; Hayasaki T; Akizawa T
    Am J Nephrol; 2021; 52(10-11):871-883. PubMed ID: 34569489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study.
    Nangaku M; Kondo K; Ueta K; Kokado Y; Kaneko G; Matsuda H; Kawaguchi Y; Komatsu Y
    Nephrol Dial Transplant; 2021 Aug; 36(9):1731-1741. PubMed ID: 33650630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enarodustat to treat anemia in chronic kidney disease.
    Fukui K; Tanaka T; Nangaku M
    Drugs Today (Barc); 2021 Aug; 57(8):491-497. PubMed ID: 34405206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Hemoglobin Response to Treatment With Enarodustat Using Pharmacometric Approach in Japanese Anemic Patients With Chronic Kidney Disease.
    Naruhashi S; Fujii T; Yamada H; Pai SM; Ninomiya N
    J Clin Pharmacol; 2023 Feb; 63(2):180-196. PubMed ID: 36057843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis.
    Akizawa T; Yamada T; Nobori K; Matsuda Y; Hayashi Y; Hayasaki T; Yamamoto H
    Kidney Int Rep; 2021 Oct; 6(10):2604-2616. PubMed ID: 34622100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anemia associated with chronic kidney disease with the HIF prolyl hydroxylase inhibitor enarodustat: A review of the evidence.
    Fujikawa R; Nagao Y; Fujioka M; Akizawa T
    Ther Apher Dial; 2022 Aug; 26(4):679-693. PubMed ID: 35218616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.
    Akizawa T; Yamaguchi Y; Otsuka T; Reusch M
    Nephron; 2020; 144(8):372-382. PubMed ID: 32580188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
    Shinozaki Y; Fukui K; Kobayashi H; Yoshiuchi H; Matsuo A; Matsushita M
    Eur J Pharmacol; 2021 May; 898():173990. PubMed ID: 33657422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD.
    Akizawa T; Iwasaki M; Otsuka T; Yamaguchi Y; Reusch M
    Kidney Int Rep; 2021 Jul; 6(7):1810-1828. PubMed ID: 34307976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.
    Nangaku M; Kondo K; Kokado Y; Ueta K; Kaneko G; Tandai T; Kawaguchi Y; Komatsu Y
    J Am Soc Nephrol; 2021 Jul; 32(7):1779-1790. PubMed ID: 33883252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.
    Besarab A; Chernyavskaya E; Motylev I; Shutov E; Kumbar LM; Gurevich K; Chan DT; Leong R; Poole L; Zhong M; Saikali KG; Franco M; Hemmerich S; Yu KH; Neff TB
    J Am Soc Nephrol; 2016 Apr; 27(4):1225-33. PubMed ID: 26494833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enarodustat Treatment for Renal Anemia in Patients With Non-dialysis Chronic Kidney Disease.
    Mima A
    In Vivo; 2023; 37(2):825-829. PubMed ID: 36881056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.